798 EFFICACY OF TELAPREVIR DOSED TWICE DAILY VERSUS EVERY 8 HOURS BY IL28B GENOTYPE: RESULTS FROM THE PHASE III OPTIMIZE STUDY
Buti, M., Agarwal, K., Horsmans, Y., Sievert, W., Janczewska, E., Zeuzem, S., Nyberg, L., Brown, R.S., Hezode, C., Rizzetto, M., Parana, R., De Meyer, S., DeMasi, R., Luo, D., Witek, J.Volume:
58
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/S0168-8278(13)60800-4
Date:
April, 2013
File:
PDF, 115 KB
english, 2013